CLINICAL_TRIALS
trial_result
· 2017-08-14
Clinical Trial Update: Post-stroke Neural Plasticity With Atomoxetine [Phase 2]
Summary
Phase 2 trial evaluating atomoxetine hydrochloride for post-stroke neural plasticity has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Lumy Sawaki | Conditions: Atomoxetine Hydrochloride, Placebos | Phase 2 | Status: COMPLETED | Results posted: 2017-08-14